Reported Sep 27, 2023 · Terminated

Rasagiline Tablets 0.5mg, 30-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A., NDC…

Aurobindo Pharma USA Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Aurobindo Pharma USA Inc. · 279 Princeton Hightstown Rd · East Windsor, NJ · 08520-1401

Is this the product you have?

    • Rasagiline Tablets 0.5mg
    • 30-count bottle
    • Rx only
    • Mylan Pharmaceuticals Inc. Morgantown
    • WV 26505 U.S.A
    • NDC 0378-1270-93
Lot codes and dates
    • Lot #: 3112444
    • Exp 8/2023
Amount recalled
9,890 bottles

Where it was sold

  • Nationwide

Why it was recalled

Failed dissolution specifications - results obtained were below spec average.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Aurobindo Pharma USA Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Aug 19, 2024 · Data as of Sep 19, 6:39 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.